東方創業(600278.SH):子公司參設管理公司並由其投設血透中心
格隆匯 8 月 3日丨東方創業(600278.SH)公佈,公司控股子公司上海東鬆醫療科技股份有限公司(“東鬆醫療”)出資850萬元與東方國際集團上海投資有限公司(以下簡稱:東方投資)、江蘇費森尤斯醫院管理服務有限公司(簡稱“費森尤斯”)合資設立東方費森醫療投資管理有限公司(以工商核名為準,“管理公司”),並由管理公司投資設立全資子公司東方費森血透中心有限公司(以衞生主管部門的意見及工商核名為準,“血透中心”)。
管理公司註冊資本2500萬,其中由東方投資出資1175萬元,持股47%;東鬆醫療出資850萬元,持股34%;費森尤斯出資475萬元,持股19%。各方均以現金方式出資。管理公司下設的血透中心公司註冊資本為2500萬,由管理公司出資設立。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.